Почетна › Рак на ендометриумот › Вирџинија
Клинички испитувања за Рак на ендометриумот во Вирџинија
51 студии за Рак на ендометриумот бараат учесници на локации во Вирџинија.
Градови во Вирџинија
Официјален текст на студијата (англиски)
Testing the Addition of an Antiangiogenic Drug (Bevacizumab) to Chemotherapy (Carboplatin and Paclitaxel) Combined With Immunotherapy (Pembrolizumab) for pMMR, TP53 Mutated Endometrial Cancer
- University of Virginia Cancer Center, Charlottesville
- VCU Massey Comprehensive Cancer Center, Richmond
Се регрутираФаза 3
Возраст 18 и постари · Жени · Ажурирано 5.10.2026 · NCT07198074Targeted Therapy Directed by Genetic Testing in Treating Patients With Locally Advanced or Advanced Solid Tumors, The ComboMATCH Screening Trial
- Ballad Health Cancer Care - Bristol, Bristol
- University of Virginia Cancer Center, Charlottesville
- Inova Schar Cancer Institute, Fairfax
- и уште 5
Се регрутираФаза 2
Сите возрасти · Сите полови · Ажурирано 5.10.2026 · NCT05564377Phase I/IIa Study of AZD5335 as Monotherapy and Combination Therapy in Participants With Solid Tumors
- Research Site, Fairfax
Се регрутираФаза 1/2
Возраст од 18 до 130 · Сите полови · Ажурирано 5.10.2026 · NCT05797168A Study of PHST001 in Advanced Solid Tumors
- NEXT Oncology - Virginia, Fairfax
Се регрутираФаза 1
Возраст 18 и постари · Сите полови · Ажурирано 5.10.2026 · NCT06840886A Phase 1 Study of PLN-101095 in Adults With Advanced or Metastatic Solid Tumors
- Inova Schar Cancer Institute, Fairfax
- NEXT Virginia, Fairfax
Се регрутираФаза 1
Возраст 18 и постари · Сите полови · Ажурирано 2.10.2026 · NCT06270706The Evaluation of PC14586 in Patients With Advanced Solid Tumors Harboring a TP53 Y220C Mutation (PYNNACLE)
- Virginia Cancer Specialists, Fairfax
Се регрутираФаза 1/2
Возраст 12 и постари · Сите полови · Ажурирано 2.10.2026 · NCT04585750A Study With NKT3964 for Adults With Advanced/Metastatic Solid Tumors
- University of Virginia, Charlottesville
- NEXT Virginia, Fairfax
Се регрутираФаза 1
Возраст 19 и постари · Сите полови · Ажурирано 1.10.2026 · NCT06586957A Phase 1, First-in-Human (FIH), Open-Label, Dose-Escalation and Dose Expansion Study of the Peptide Drug Conjugate (PDC), TS-104, as a Monotherapy in Subjects With Select Advanced Solid Tumors
- Site 04, Fairfax
Се регрутираФаза 1
Возраст 18 и постари · Сите полови · Ажурирано 30.9.2026 · NCT07814248Leveraging Methylated DNA Markers (MDMs) in the Detection of Endometrial Cancer, Ovarian Cancer, and Cervical Cancer
- Virginia Commonwealth University/ Massey Cancer Center, Richmond
Се регрутираНабљудувачка студија
Возраст 18 и постари · Жени · Ажурирано 29.9.2026 · NCT05051722Study of AVZO-021 in Patients With Advanced Solid Tumors
- Avenzo Therapeutics Recruiting Site, Fairfax
Се регрутираФаза 1/2
Возраст 18 и постари · Сите полови · Ажурирано 28.9.2026 · NCT05867251Testing Nivolumab With or Without Ipilimumab in Deficient Mismatch Repair System (dMMR) Recurrent Endometrial Carcinoma
- University of Virginia Cancer Center, Charlottesville
Се регрутираФаза 2
Возраст 18 и постари · Жени · Ажурирано 28.9.2026 · NCT05112601Study of REGN4018 (Ubamatamab) Administered Alone or in Combination With Cemiplimab in Adult Patients With Recurrent Ovarian Cancer or Other Recurrent Mucin-16 Expressing (MUC16+) Cancers
- Virginia Commonwealth University, Richmond
Се регрутираФаза 1/2
Возраст 18 и постари · Жени · Ажурирано 25.9.2026 · NCT03564340Adjuvant Therapy in POLE-Mutated and p53-Wildtype/NSMP Early Stage Endometrial Cancer RAINBO BLUE & TAPER
- University of Virginia Cancer Center, Charlottesville
- Virginia Commonwealth University, Richmond
Се регрутираФаза 2
Возраст 18 и постари · Жени · Ажурирано 24.9.2026 · NCT05640999Study of Elironrasib and Daraxonrasib as Monotherapies and Combination Therapy in Participants With Advanced KRAS G12C Mutant Solid Tumors
- NEXT Oncology Virginia, Fairfax
Се регрутираФаза 1/2
Возраст 18 и постари · Сите полови · Ажурирано 22.9.2026 · NCT06128551Evaluate BL-B01D1 in Patients With Metastatic or Unresectable Non-Small Cell Lung Cancer (NSCLC) and Other Solid Tumors
- Virginia Cancer Specialists, Fairfax
Се регрутираФаза 1
Возраст 18 и постари · Сите полови · Ажурирано 21.9.2026 · NCT05983432A Study to Compare Sacituzumab Tirumotecan (MK-2870) in Combination With Pembrolizumab (MK-3475) Versus Pembrolizumab Alone as Treatment in Participants With Mismatch Repair Proficient Endometrial Cancer (MK-2870-033/TroFuse-033/GOG-3119/ENGOT-en29)
- Inova Schar Cancer Institute ( Site 6003), Fairfax
- Virginia Cancer Specialists (VCS) ( Site 8008), Fairfax
- VCU Health Adult Outpatient Pavillion ( Site 5000), Richmond
Се регрутираФаза 3
Возраст 18 и постари · Жени · Ажурирано 17.9.2026 · NCT06952504A Phase 1/2 Trial of TER-2013 in Patients With Solid Tumors Harboring AKT/PI3K/PTEN Pathway Alterations
- NEXT Oncology, Fairfax
Се регрутираФаза 1/2
Возраст 18 и постари · Сите полови · Ажурирано 17.9.2026 · NCT07109726Open Label Study to Evaluate BL-M07D1 in HER2 Expressing Malignant Solid Tumors
- Virginia Cancer Specialists, Fairfax
Се регрутираФаза 1
Возраст 18 и постари · Сите полови · Ажурирано 10.9.2026 · NCT06293898Study to Assess the Efficacy and Safety of Rina-S Compared to Treatment of Investigator's Choice in Participants With Endometrial Cancer
- University of Virginia, Charlottesville
Се регрутираФаза 3
Возраст 18 и постари · Жени · Ажурирано 9.9.2026 · NCT07166094Phase 1 Study to Assess Safety, Tolerability, Pharmacokinetics, Immunogenicity, and Antitumor Activity of ARR-002 in Advanced or Metastatic Ovarian or Endometrial Cancer.
- NEXT Oncology, Fairfax
Се регрутираФаза 1
Возраст 18 и постари · Жени · Ажурирано 3.9.2026 · NCT07755436DESTINY-Endometrial01: A Phase III Study of Trastuzumab Deruxtecan Plus Rilvegostomig or Pembrolizumab as First-Line Treatment of HER2-Expressing (IHC 3+/2+), Mismatch Repair Proficient (pMMR) Endometrial Cancer
- Research Site, Charlottesville
- Research Site, Fairfax
Се регрутираФаза 3
Возраст 18 и постари · Жени · Ажурирано 3.9.2026 · NCT06989112A Study of STRO-004 in Adults With Refractory/Recurrent Metastatic Cancer
- NEXT Virginia, Fairfax
Се регрутираФаза 1
Возраст 18 и постари · Сите полови · Ажурирано 27.8.2026 · NCT07227168A Study of Mutant Selective-Inhibitor (CGT6297), in Patients With Advanced Solid Tumors
- NEXT Virginia, Fairfax
Се регрутираФаза 1
Возраст 18 и постари · Сите полови · Ажурирано 26.8.2026 · NCT07383506Phase 1, Safety and Tolerability Study of XmAb541 in Advanced Solid Tumors
- University of Virginia, Charlottesville
Се регрутираФаза 1
Возраст 15 и постари · Сите полови · Ажурирано 25.8.2026 · NCT06276491A Phase 2 Study of ACR-368 in Endometrial Adenocarcinoma
- University of Virginia Health System, Charlottesville
Се регрутираФаза 2
Возраст 18 и постари · Жени · Ажурирано 21.8.2026 · NCT05548296A Phase 1 Study of LNCB74 in Advanced Solid Tumors
- Inova Schar Cancer Institute, Falls Church
Се регрутираФаза 1
Возраст 18 и постари · Сите полови · Ажурирано 21.8.2026 · NCT06774963A Study of Tulmimetostat DZR123 (CPI-0209) in Patients With Advanced Solid Tumors and Lymphomas
- University of Virginia Health System, Charlottesville
Се регрутираФаза 1/2
Возраст 18 и постари · Сите полови · Ажурирано 19.8.2026 · NCT04104776A Phase 1 Study of NRM-823 in Participants With Locally Advanced or Metastatic Refractory Solid Tumors
- Normunity Investigational Site, Fairfax
Се регрутираФаза 1
Возраст 18 и постари · Сите полови · Ажурирано 18.8.2026 · NCT07182149FOG-001 in Locally Advanced or Metastatic Solid Tumors
- University of Virginia, Charlottesville
Се регрутираФаза 1/2
Возраст 18 и постари · Сите полови · Ажурирано 17.8.2026 · NCT05919264A Study to Evaluate the Efficacy and Safety of Ifinatamab Deruxtecan (I-DXd) in Subjects With Recurrent or Metastatic Solid Tumors (IDeate-PanTumor02)
- Virginia Cancer Specialists, Fairfax
Се регрутираФаза 1/2
Возраст 18 и постари · Сите полови · Ажурирано 5.8.2026 · NCT06330064Study Evaluating the Safety and Efficacy of HWK-007, a PTK7-directed Antibody Drug Conjugate in Participants With Advanced Solid Tumors
- NEXT Oncology - Virginia Cancer Specialists, Fairfax
Се регрутираФаза 1
Возраст 18 и постари · Сите полови · Ажурирано 5.8.2026 · NCT07444814Rinatabart Sesutecan (Rina-S, PRO1184, GEN1184) for Advanced Solid Tumors (GCT1184-01/ PRO1184-001)
- USOR Virginia Cancer Specialists, Fairfax
- USOR Virginia Oncology Associates, Norfolk
Се регрутираФаза 1/2
Возраст 18 и постари · Сите полови · Ажурирано 4.8.2026 · NCT05579366A Study of ART0380 for the Treatment of Advanced or Metastatic Solid Tumors
- Virginia Cancer Specialists, Fairfax
Се регрутираФаза 1/2
Возраст 18 и постари · Сите полови · Ажурирано 30.7.2026 · NCT04657068Puxitatug Samrotecan (AZD8205) Monotherapy vs Chemotherapy in B7-H4-selected Endometrial Cancer (Bluestar-Endometrial01)
- Research Site, Fairfax
- Research Site, Falls Church
- Research Site, Norfolk
- и уште 2
Се регрутираФаза 3
Возраст 18 и постари · Жени · Ажурирано 29.7.2026 · NCT07044336A Study of PF-08046054/SGN-PDL1V in Advanced Solid Tumors
- NEXT Virginia, Fairfax
Се регрутираФаза 1
Возраст 18 и постари · Сите полови · Ажурирано 22.7.2026 · NCT05208762Study of RGT-490 in Patients With PIK3CA-Mutated Advanced Solid Tumors
- NEXT Virginia, Fairfax
Се регрутираФаза 1
Возраст 18 и постари · Сите полови · Ажурирано 22.7.2026 · NCT07524322Relacorilant in Combination With Different Treatment Regimens in Patients With Gynecological Cancers
- 522, Fairfax
- 300, Norfolk
Се регрутираФаза 2
Возраст 18 и постари · Жени · Ажурирано 16.7.2026 · NCT06906341First-in-Human Study of Tersolisib (STX-478) as Monotherapy and in Combination With Other Antineoplastic Agents in Participants With Advanced Solid Tumors
- USO-Virginia Cancer Specialists, PC, Fairfax
Се регрутираФаза 1/2
Возраст 18 и постари · Сите полови · Ажурирано 7.7.2026 · NCT05768139A Phase 1 Dose-escalation Trial of KST-6051 in Participants With Advanced Solid Tumors With Kirsten Rat Sarcoma Viral Oncogene Homolog (KRAS) Mutation
- NEXT Virginia, Fairfax
Се регрутираФаза 1
Возраст 18 и постари · Сите полови · Ажурирано 29.6.2026 · NCT07458347A Study of Emiltatug Ledadotin (Emi-Le) in Participants With Solid Tumors
- NEXT Oncology Virginia, Fairfax
Се регрутираФаза 1/2
Возраст 18 и постари · Сите полови · Ажурирано 29.6.2026 · NCT05377996Од ClinicalTrials.gov, податоци преземени 6.10.2026. Секоја студија ги поставува своите услови за вклучување; тимот на студијата одлучува кој може да учествува.